Christina Scherer

Vice President & Head, Early Portfolio Management @ Acrivon Therapeutics, Inc.

Country

United States

City

Cambridge

Industry

Biotechnology

Skill

Infectious Diseases, Biochemistry, PCR, High Throughput Screening, Biotechnology, Cell Culture, Lifesciences, Genomics, Immunology, Cell Biology, Molecular Biology, Bioinformatics, Drug Discovery, Assay Development, Genetics, Protein Chemistry, qPCR, Life Sciences

Experience

Vice President & Head, Early Portfolio Management

Acrivon Therapeutics, Inc.

2024-9 - Presente · 2 a 2 m

Executive Director & Head, Early Portfolio Management

Acrivon Therapeutics, Inc.

2023-9 - 2024-9 · 1 a 1 m

Head, Early Portfolio Management

Acrivon Therapeutics, Inc.

2022-4 - 2023-9 · 1 a 6 m

Senior Director, Product and Portfolio Development

Anokion

2019-9 - 2022-3 · 2 a 7 m

Senior Director, Product and Portfolio Development

Kanyos Bio

2019-1 - 2019-8 · 8 m

Director, Alliance and Program Management

Kanyos Bio

2015-10 - 2018-12 · 3 a 3 m

Director, Anti-infectives Discovery, Therapeutics Platform

The Broad Instititute

2013-7 - 2015-10 · 2 a 4 m

Cambridge, MA

Manager, Infectious Diseases Biology

Broad Institute of MIT and Harvard

2009-1 - 2013-6 · 4 a 6 m

Chemical Biology Platform

VP Research Collaborations

Kineta, Inc.

2008-1 - 2008-12 · 1 a

Director of Research

Illumigen Biosciences

2002-5 - 2007-12 · 5 a 8 m

Senior Scientist

Otogene USA

2000-5 - 2001-12 · 1 a 8 m

Postdoctoral researcher

University of Washington

1995 - 2000 · 5 a

Graduate student

MIT

1988 - 1995 · 7 a

Education

Amherst College

Biology

Massachusetts Institute of Technology

Biology